Immunoproteasome Inhibition Impairs Differentiation but Not Survival of T Helper 17 Cells
Cells · 2025
DOI: 10.3390/cells14100689 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Franziska Oliveri und 3 weiteren Autor:innen. Beteiligte Einrichtung: Biotechnology Institute Thurgau at the University of Konstanz, 8280 Kreuzlingen, Switzerland. Hauptthemen laut MEDLINE: Th17 Cells, Cell Differentiation, Proteasome Endopeptidase Complex, Proteasome Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Kezar Life Science, German Research Foundation (DFG).
Abstract (Originalsprache)
Autoimmune and inflammatory diseases are characterized by aberrant immune responses. The immunoproteasome was proposed as a target for such Th cell-mediated diseases due to its role in the activation, differentiation and function of T cells. Even though many studies demonstrated reductions in Th17 cells upon immunoproteasome inhibition, it is still unclear if the differentiation or survival of these cells is affected. Therefore, this study used DSS-induced colitis and house dust mite airway inflammation mouse models to investigate the effect of immunoproteasome inhibition on Th17 cells and Tregs at different time points. Th17 cells were almost abolished when immunoproteasome inhibition was applied continuously in DSS-induced colitis. In contrast, immunoproteasome inhibition did not decrease levels of already differentiated Th17 cells and did not enhance Treg induction. Dendritic cells were barely affected by immunoproteasome inhibition. Moreover, immunoproteasome inhibition reduced T cell activation in vitro and in vivo, suggesting impaired activation as the underlying mechanism for reduced Th17 differentiation. In conclusion, immunoproteasome inhibition reduces Th17 differentiation by impairing the activation of naïve T cells, but it does not affect the survival of already-differentiated Th17 cells and Tregs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biotechnology Institute Thurgau at the University of Konstanz, 8280 Kreuzlingen, Switzerland.
- Division of Immunology, Department of Biology, University of Konstanz, 78457 Konstanz, Germany.
- Department of Research, Kezar Life Sciences, Inc., South San Francisco, CA 94080, USA.
ORCID-Profile: Franziska Oliveri, Dennis Mink, Tony Muchamuel, Michael Basler
Förderung
- Deutsche Forschungsgemeinschaft
- Kezar Life Science
- German Research Foundation (DFG)
Zitieren
APA
Oliveri, F., Mink, D., Muchamuel, T., & Basler, M. (2025). Immunoproteasome Inhibition Impairs Differentiation but Not Survival of T Helper 17 Cells. Cells. https://doi.org/10.3390/cells14100689
Vancouver
Oliveri F, Mink D, Muchamuel T, Basler M. Immunoproteasome Inhibition Impairs Differentiation but Not Survival of T Helper 17 Cells. Cells. 2025. doi:10.3390/cells14100689
BibTeX
@article{Oliveri2025,
author = {Oliveri, Franziska and Mink, Dennis and Muchamuel, Tony and Basler, Michael},
title = {Immunoproteasome Inhibition Impairs Differentiation but Not Survival of T Helper 17 Cells},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14100689}
}
EUVIMED